Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	55.26	6.92	16.33	33.09	52.97
Cash & Short-Term Investments	55.26	6.92	16.33	33.09	52.97
Cash Growth	698.24%	-57.61%	-50.64%	-37.53%	-
Other Receivables	-	-	0.04	-	-
Total Trade Receivables	-	-	0.04	-	-
Other Current Assets	1.2	0.45	0.32	0.99	0.33
Total Current Assets	56.46	7.37	16.69	34.08	53.3
Net Property, Plant & Equipment	-	0.12	0.22	0.63	0.02
Other Intangible Assets	3.78	7.31	7.94	8.57	-
Goodwill	-	1.26	1.26	1.26	-
Other Long-Term Assets	-	-	-	0.64	-
Total Assets	60.24	16.06	26.12	45.18	53.32
Accounts Payable	1.13	1.12	2.55	1.48	0.45
Current Portion of Leases	-	-	0.08	0.16	-
Other Current Liabilities	3.84	-	-	0.24	-
Total Current Liabilities	4.97	1.12	2.63	1.88	0.45
Long-Term Leases	-	-	-	0.34	-
Other Long-Term Liabilities	0.05	0.16	0.08	0.46	1.45
Total Long-Term Liabilities	0.05	0.16	0.08	0.8	1.45
Total Liabilities	5.02	1.28	2.72	2.68	1.9
Common Stock	0	0	0	0	0.02
Additional Paid-in Capital	125.21	64.37	58.72	61.86	53.63
Accumulated Other Comprehensive Income	0.02	-0.01	-0	-0	-0.01
Retained Earnings	-70.01	-49.58	-35.32	-19.36	-2.21
Shareholders' Equity	55.22	14.78	23.4	42.5	51.42
Total Liabilities & Equity	60.24	16.06	26.12	45.18	53.32
Total Debt	0	0	0.08	0.5	0
Net Cash (Debt)	55.26	6.92	16.25	32.58	52.97
Net Cash Growth	698.24%	-57.40%	-50.13%	-38.48%	-
Net Cash Per Share	7.86	6.32	13.25	25.81	101.81
Book Value	55.22	14.78	23.4	42.5	51.42
Book Value Per Share	7.85	13.49	19.08	33.67	98.84
Tangible Book Value	51.44	6.21	14.19	32.66	51.42
Tangible Book Value Per Share	7.32	5.66	11.57	25.88	98.84

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q